Republic of Korea Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 294 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.3 Healthcare Policy

4 Wound Care Management in Republic of Korea

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in Republic of Korea

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Hemostats Overall Volume (2000-2012)

5.2.3 Tissue Sealants Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share (2000-2012)

5.5 Wound Closure Devices Company Share (2000-2012)

6 Ostomy in Republic of Korea

6.1 Ostomy Overall Revenue (2000-2012)

6.2 Ostomy Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advanced Wound Management in Republic of Korea

7.1 Advanced Wound Management Overall Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management in Republic of Korea

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2000-2012)

8.5 Traditional Wound Management Company Share (2000-2012)

9 Compression Therapy in Republic of Korea

9.1 Compression Therapy Overall Revenue (2000-2012)

9.2 Compression Therapy Category Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2000-2012)

9.5 Compression Therapy Company Share (2000-2012)

10 Covidien Ltd./Tyco Healthcare Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Imaging Solutions

10.2.2 Medical Devices

10.2.3 Medical Supplies

10.2.4 Pharmaceutical Products

10.2.5 Retail Products

10.2.6 Products

10.2.7 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Covidien Ltd./Tyco Healthcare Strengths

10.4.2 Covidien Ltd./Tyco Healthcare Weaknesses

10.4.3 Covidien Ltd./Tyco Healthcare Opportunities

10.4.4 Covidien Ltd./Tyco Healthcare Threats

10.5 Financial and Operational Review

10.5.1 Financial Statements

10.5.2 Financial Ratios

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Covidien Signs An Agreement With Allergan

10.7.2 Covidien Acquires Scandius Biomedical

10.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million

10.7.4 Covidien And BioSynthema Enter Into Licensing Agreement

10.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien

10.7.6 Covidien To Sell European Incontinence Business

10.7.7 Covidien To Acquire Tissue Science Laboratories

10.8 Recent Developments

10.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007

10.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend

10.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case

10.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results

10.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend

10.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results

10.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results

10.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent

10.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend

10.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results

10.9 Covidien Ltd./Tyco Healthcare Pipeline Products

10.9.1 PleuraSeal Lung Sealant System

10.9.2 Sandman Intro CPAP Device

11 3M Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Consumer and Office

11.2.2 Display and Graphics

11.2.3 Electro and Communications

11.2.4 Health Care

11.2.5 Industrial and Transportation

11.2.6 Safety, Security and Protection Services

11.2.7 Products

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 3M Company Strengths

3M Company Weaknesses

3M Company Opportunities

3M Company Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 3M Canada Acquires Les Entreprises Solumed

11.7.2 3M Acquires Bondo

11.7.3 3M Acquires Lingualcare

11.7.4 3M Acquires Abzil Industria E Comercio

11.7.5 3M Acquires Neo Plast

11.7.6 3M Acquires Assets Of DMS Chile

11.7.7 3M Acquires Business Of Innovative Paper Technologies

11.7.8 3M Acquires Powell

11.7.9 Gen-Probe Signs An Agreement With 3M Company

11.7.10 3M Acquires Acolyte Biomedica

11.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp.

11.7.12 3M Sells Its Pharmaceutical Business To Meda AB

11.7.13 3M Acquires SoftMed Systems

11.7.14 3M Sells its Pharmaceuticals Business to Graceway

11.7.15 Gen-Probe Signs An Agreement With 3M

11.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital

11.7.17 3M Acquires Biotrace International

11.7.18 Ekahau Secures $16 Million In Additional Funding

11.7.19 3M Acquires Brontes Technologies

11.7.20 3M acquires Nylonge Corp

11.7.21 3M Signs An Agreement With ClozeX Medical

11.7.22 3M Acquires OMNII Oral Pharmaceuticals

11.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway

11.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB

11.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital

11.7.26 3M Acquires Accuspray Application Technologies Inc.

11.7.27 3M to acquire Rochford Thompson Equipment

11.7.28 3M To Acquire Aearo Technologies From Permira

11.7.29 Permira To Sell Aearo Technologies To 3M

11.8 Recent Developments

11.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses

11.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State

11.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia

11.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia

11.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year

11.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend

11.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery

11.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend

11.8.9 May 08, 2007: 3M Declares Quarterly Dividend

11.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests

12 Ethicon, Inc. Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Products

12.3 Locations And Subsidiaries

12.4 Financial Deals Landscape

12.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON

12.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON

12.4.3 ETHICON Acquires Vascular Control Systems

12.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON

13 Smith & Nephew Plc Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 Advanced Wound Management

13.2.2 Endoscopy

13.2.3 Reconstruction

13.2.4 Trauma and Clinical Therapies

13.2.5 Products

13.2.6 History

13.3 Value Chain Analysis

13.3.1 Manufacturing

13.3.2 Product Development

13.3.3 Sales and Marketing

13.4 SWOT Analysis

13.4.1 Smith & Nephew Plc Strengths

13.4.2 Smith & Nephew Plc Weaknesses

13.4.3 Smith & Nephew Plc Opportunities

13.4.4 Smith & Nephew Plc Threats

13.5 Financial and Operational Review

13.6 Locations And Subsidiaries

13.7 Financial Deals Landscape

13.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein

13.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services

13.7.3 Smith & Nephew Acquires Plus Orthopedics Holding

13.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement

13.7.5 Smith & Nephew Acquires BlueSky Medical Group

13.7.6 Smith & Nephew Enters Into An Agreement With Covalon

13.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories

13.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew

13.7.9 Smith & Nephew Acquires Osteobiologics

13.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement

13.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity

13.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew

13.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies

13.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft

13.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement

13.7.16 Smith & Nephew Acquires VERSAJET From HydroCision

13.7.17 Smith & Nephew Terminates Acquisition Of Biomet

13.8 Recent Developments

13.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend

13.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results

13.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation

13.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM

13.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails

13.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend

13.8.7 May 03, 2007: Smith & Nephew Appoints New CEO

13.9 Smith & Nephew Plc Pipeline Products

13.9.1 R3 Modular resurfacing Acetabular system

13.9.2 R3 Ceramic-on-ceramic Acetabular System

14 The HARTMANN GROUP Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Incontinence Management

14.2.2 Operating Theater Management

14.2.3 Other GROUP Activities

14.2.4 Wound Management

14.2.5 Products

14.2.6 History

14.3 Value Chain Analysis

14.3.1 Manufacturing

14.3.2 Product Development

14.3.3 Sales and Marketing

14.4 SWOT Analysis

14.4.1 HARTMANN GROUP Strengths

14.4.2 HARTMANN GROUP Weaknesses

14.4.3 HARTMANN GROUP Opportunities

14.4.4 HARTMANN GROUP Threats

14.5 Financial and Operational Review

14.6 Locations And Subsidiaries

14.7 Recent Developments

14.7.1 Mar 17, 2008: Hartmann Declares 2007 Results

14.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia

14.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm

14.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Classification

15.1.2 Premarket Notification for Class I Devices

15.1.3 Pre-market Approval for Class II, III and IV Devices

15.1.4 License Fee

15.1.5 License Application Processing Duration

15.2 Post-market Surveillance

16 Pricing and Reimbursement

17 Distribution Structure

17.1 Distribution Structure

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List of Tables

Table 1: Hospital Wards by Specialty in Republic of Korea, 2003-2007

Table 2: Doctors by Specialty in Republic of Korea, 2003-2007

Table 3: Healthcare Institutions in Republic of Korea, 2001-2005

Table 4: Healthcare Personnel in Republic of Korea, 1975-2002

Table 5: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), 2000-2012

Table 6: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 7: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 8: Wound Care Management, Republic of Korea, Category Revenues ($ mn), 2000-2012

Table 9: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Historic, 2000-2007

Table 10: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Forecast, 2007-2012

Table 11: Wound Care Management, Republic of Korea, Category Volume (Units), 2000-2012

Table 12: Wound Care Management, Republic of Korea, Category Volume (Units), Historic, 2000-2007

Table 13: Wound Care Management, Republic of Korea, Category Volume (Units), Forecast, 2007-2012

Table 14: Wound Care Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006

Table 15: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 16: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 17: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Historic, 2000-2007

Table 18: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 19: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 20: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 21: Hemostats, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 22: Hemostats, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 23: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 24: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 25: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 26: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 27: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 28: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 29: Hemostats, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 30: Hemostats, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 31: Tissue Sealants, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 32: Tissue Sealants, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 33: Hemostats, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 34: Hemostats, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 35: Tissue Sealants, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 36: Tissue Sealants, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 37: Skin Closure Devices, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 38: Skin Closure Devices, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 39: Wound Closure Devices, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006

Table 40: Wound Closure Devices, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006

Table 41: Ostomy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 42: Ostomy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 43: Ostomy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 44: Ostomy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 45: Ostomy, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 46: Ostomy, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 47: Ostomy, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006

Table 48: Ostomy, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006

Table 49: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 50: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 51: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 52: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 53: Advanced Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 54: Advanced Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 55: Advanced Wound Management, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006

Table 56: Advanced Wound Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006

Table 57: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 58: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 59: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 60: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 61: Traditional Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 62: Traditional Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 63: Traditional Wound Management, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006

Table 64: Traditional Wound Management, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006

Table 65: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Table 66: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Table 67: Compression Therapy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Table 68: Compression Therapy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Table 69: Compression Therapy, Republic of Korea, Average Price ($), Historic, 2000-2007

Table 70: Compression Therapy, Republic of Korea, Average Price ($), Forecast, 2007-2012

Table 71: Compression Therapy, Republic of Korea, Distribution Share by Revenue ($ mn), 2005-2006

Table 72: Compression Therapy, Republic of Korea, Company Share by Revenue ($ mn), 2005-2006

Table 73: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007

Table 74: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007

Table 75: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007

Table 76: Covidien Ltd./Tyco Healthcare, Other Locations

Table 77: Covidien Ltd./Tyco Healthcare, Subsidiaries

Table 78: 3M Company, SWOT Analysis, 2006

Table 79: 3M Company, Financial Statements, USD Million, 2002-2006

Table 80: 3M Company, Financial and Operational Overview, USD Million, 2002-2006

Table 81: 3M Company, Subsidiaries

Table 82: Ethicon, Inc., Other Locations

Table 83: Ethicon, Inc., Subsidiaries

Table 84: Smith & Nephew Plc, SWOT Analysis, 2006

Table 85: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006

Table 86: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006

Table 87: Smith & Nephew Plc, Other Locations

Table 88: HARTMANN GROUP, SWOT Analysis, 2006

Table 89: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006

Table 90: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006

Table 91: HARTMANN GROUP, Subsidiaries

Table 92: Classification of Medical Equipment in Republic of Korea

Table 93: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.1 List of Figures

Figure 1: Healthcare Financing in Republic of Korea, 2007

Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006

Figure 3: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), 2000-2012

Figure 4: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 5: Wound Care Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 6: Wound Care Management, Republic of Korea, Category Revenues ($ mn), 2000-2012

Figure 7: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Historic, 2000-2007

Figure 8: Wound Care Management, Republic of Korea, Category Revenues ($ mn), Forecast, 2007-2012

Figure 9: Wound Care Management, Republic of Korea, Category Volume (Units), 2000-2012

Figure 10: Wound Care Management, Republic of Korea, Category Volume (Units), Historic, 2000-2007

Figure 11: Wound Care Management, Republic of Korea, Category Volume (Units), Forecast, 2007-2012

Figure 12: Wound Care Management, Republic of Korea, Company Share (%), 2006

Figure 13: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 14: Wound Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 15: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 16: Wound Closure Devices, Republic of Korea, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 17: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 18: Skin Closure Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 19: Hemostats, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 20: Hemostats, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 21: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 22: Tissue Sealants, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 23: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 24: Wound Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 25: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 26: Skin Closure Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 27: Hemostats, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 28: Hemostats, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 29: Tissue Sealants, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 30: Tissue Sealants, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 31: Hemostats, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 32: Hemostats, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 33: Tissue Sealants, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 34: Tissue Sealants, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 35: Skin Closure Devices, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 36: Skin Closure Devices, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 37: Wound Closure Devices, Republic of Korea, Distribution Share (%), 2006

Figure 38: Wound Closure Devices, Republic of Korea, Company Share (%), 2006

Figure 39: Ostomy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 40: Ostomy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 41: Ostomy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 42: Ostomy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 43: Ostomy, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 44: Ostomy, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 45: Ostomy, Republic of Korea, Company Share (%), 2006

Figure 46: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 47: Advanced Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 48: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 49: Advanced Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 50: Advanced Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 51: Advanced Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 52: Advanced Wound Management, Republic of Korea, Distribution Share (%), 2006

Figure 53: Advanced Wound Management, Republic of Korea, Company Share (%), 2006

Figure 54: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 55: Traditional Wound Management, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 56: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 57: Traditional Wound Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 58: Traditional Wound Management, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 59: Traditional Wound Management, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 60: Traditional Wound Management, Republic of Korea, Distribution Share (%), 2006

Figure 61: Traditional Wound Management, Republic of Korea, Company Share (%), 2006

Figure 62: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007

Figure 63: Compression Therapy, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 64: Compression Therapy, Republic of Korea, Overall Volume (Units), Historic, 2000-2007

Figure 65: Compression Therapy, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012

Figure 66: Compression Therapy, Republic of Korea, Average Price ($), Historic, 2000-2007

Figure 67: Compression Therapy, Republic of Korea, Average Price ($), Forecast, 2007-2012

Figure 68: Compression Therapy, Republic of Korea, Distribution Share (%), 2006

Figure 69: Compression Therapy, Republic of Korea, Company Share (%), 2006

Figure 70: Covidien Ltd./Tyco Healthcare, Value Chain Analysis

Figure 71: 3M Company, Value Chain Analysis

Figure 72: Smith & Nephew Plc, Value Chain Analysis

Figure 73: HARTMANN GROUP, Value Chain Analysis

Figure 74: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007

Figure 75: Medical Device Pricing System in Republic of Korea, 2007

Figure 76: Global Markets Direct Methodology

Abstract

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.